Correlation Between Verastem and Celldex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Verastem and Celldex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Celldex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verastem and Celldex Therapeutics, you can compare the effects of market volatilities on Verastem and Celldex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Celldex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Celldex Therapeutics.

Diversification Opportunities for Verastem and Celldex Therapeutics

-0.64

Correlation Coefficient

Verastem  Celldex Therapeutics

Excellent diversification

The 3 months correlation between Verastem and Celldex is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Celldex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Celldex Therapeutics and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Celldex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Celldex Therapeutics has no effect on the direction of Verastem i.e., Verastem and Celldex Therapeutics go up and down completely randomly.

Pair Corralation between Verastem and Celldex Therapeutics

Given the investment horizon of 90 days Verastem is expected to under-perform the Celldex Therapeutics. In addition to that, Verastem is 2.01 times more volatile than Celldex Therapeutics. It trades about -0.37 of its total potential returns per unit of risk. Celldex Therapeutics is currently generating about -0.16 per unit of volatility. If you would invest  2,744  in Celldex Therapeutics on September 29, 2024 and sell it today you would lose (205.00) from holding Celldex Therapeutics or give up 7.47% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Verastem  vs.  Celldex Therapeutics

Verastem

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.

Celldex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Celldex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Verastem and Celldex Therapeutics

The main advantage of trading using opposite Verastem and Celldex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Celldex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celldex Therapeutics will offset losses from the drop in Celldex Therapeutics' long position.

The idea behind Verastem and Celldex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.